ELXR Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Elixxer Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.15 |
| 52 Week High | CA$1.15 |
| 52 Week Low | CA$1.15 |
| Beta | 0.87 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -23.33% |
| 5 Year Change | -85.63% |
| Change since IPO | -94.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELXR | CA Capital Markets | CA Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -0.5% |
| 1Y | n/a | 60.1% | 17.7% |
Return vs Industry: Insufficient data to determine how ELXR performed against the Canadian Capital Markets industry.
Return vs Market: Insufficient data to determine how ELXR performed against the Canadian Market.
Price Volatility
| ELXR volatility | |
|---|---|
| ELXR Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.9% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ELXR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ELXR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ferras Zalt | n/a |
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd.
Elixxer Ltd. Fundamentals Summary
| ELXR fundamental statistics | |
|---|---|
| Market cap | CA$13.04m |
| Earnings (TTM) | -CA$6.17m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.1x
P/E RatioIs ELXR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELXR income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$6.17m |
| Earnings | -CA$6.17m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -104.8% |
How did ELXR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/23 01:33 |
| End of Day Share Price | 2024/07/23 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Elixxer Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Patrick Smith | Ubika Research |